Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
The TheraPRO ® CHO Media System, a GS CHO cell culture media system, has been launched by Lonza to simply processes and optimize productivity and protein quality when used with GS-CHO cell lines. The ...